Promising results for cancer-immunotherapies revealed!

lab image
Are you looking for a
specific medicine?
Promising news on the immunotherapies front! Impressive results have been published last week regarding two new immunotherapies, pembrolizumab and nivolumab, treating patients diagnosed with melanoma, non-small cell lung cancer and renal cancer.

Data from phase 3 trials for the breakthrough immunotherapies pembrolizumab and nivolumab have shown exiting results for the treatment of melanoma, non-small cell lung cancer and renal cancer. The data was presented last week at the convention of the American Society of Clinical Oncology (ASCO) 2015.

Many media have reported about these results, a short overview can be found below:

New Class of Drugs Shows More Promise in Treating Cancer  New York Times By Andrew Pollack, May 29, 2015
Lung cancer therapy is 'milestone' BBC By James Gallagher, May 30, 2015

Bristol-Myers Squibb Has A Cancer Breakthrough. Here's Why It Should Cut The Price  Forbes By Matthey Herper, June 1, 2015

©TheSocialMedwork





Comments



Comment



Related Articles

Promising Developments in Treatment of Multiple Myeloma!

Darzalex (daratumumab) combination under review as first-line option


Telling your child you have cancer

Suggestions from cancer survivors and their children


Registered with the Dutch Ministry of Health as an independent intermediary, Registration number 6730 BEM
Registered as a USA Delaware LLC.



Our service uses cookies.